Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 30:18:2629-2639.
doi: 10.2147/DMSO.S507171. eCollection 2025.

Advances in the Epigenetic Mechanisms of Diabetic Nephropathy Pathogenesis

Affiliations
Review

Advances in the Epigenetic Mechanisms of Diabetic Nephropathy Pathogenesis

Changlong Zhang et al. Diabetes Metab Syndr Obes. .

Abstract

Diabetic nephropathy (DN) is one of the most severe microvascular complications of diabetes and a leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD). While traditional research has linked the onset of DN to factors such as metabolic dysregulation, inflammation, and oxidative stress, these mechanisms alone fail to fully explain the complex pathological features and individual variability of DN. In recent years, epigenetic research has provided new insights, revealing the critical roles of DNA methylation, histone modifications, and non-coding RNAs in the development of DN. DNA methylation regulates gene expression by altering methylation levels in promoter regions, affecting genes involved in inflammation and fibrosis. Histone modifications, including acetylation and methylation, influence gene transcription by altering chromatin structure. Additionally, non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play essential roles in gene expression networks. This review summarizes the latest advances in understanding these epigenetic mechanisms in DN pathogenesis, explores their roles in regulating inflammation, fibrosis, and cell damage, and discusses their potential applications in the diagnosis and treatment of DN. Further investigation into epigenetic modifications holds promise for identifying novel diagnostic markers and personalized therapeutic strategies for DN.

Keywords: DNA methylation; diabetic nephropathy; epigenetics; histone modifications; non-coding RNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this work.

Figures

Figure 1
Figure 1
Epigenetic Regulation of Gene Expression.
Figure 2
Figure 2
Molecular Mechanism of DNA Methylation.
Figure 3
Figure 3
Three-dimensional Structure of Histones.

Similar articles

References

    1. Chen Z, Malek V, Natarajan R. Update: the role of epigenetics in the metabolic memory of diabetic complications. Am J Physiol Renal Physiol. 2024;327(3):F327–f339. doi: 10.1152/ajprenal.00115.2024 - DOI - PMC - PubMed
    1. Natesan V, Kim SJ. Diabetic nephropathy - a review of risk factors, progression, mechanism, and dietary management. Biomol Ther. 2021;29(4):365–372. PMID: 33888647; PMCID: PMC8255138. doi: 10.4062/biomolther.2020.204 - DOI - PMC - PubMed
    1. Chen Z, Natarajan R. Epigenetic modifications in metabolic memory: what are the memories, and can we erase them? Am J Physiol Cell Physiol. 2022;323(2):C570–c582. doi: 10.1152/ajpcell.00201.2022 - DOI - PMC - PubMed
    1. Kushwaha K, Garg SS, Gupta J. Targeting epigenetic regulators for treating diabetic nephropathy. Biochimie. 2022;202:146–158. doi: 10.1016/j.biochi.2022.08.001 - DOI - PubMed
    1. Tang G, Li S, Zhang C, Chen H, Wang N, Feng Y. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B. 2021;11(9):2749–2767. PMID: 34589395; PMCID: PMC8463270. doi: 10.1016/j.apsb.2020.12.020 - DOI - PMC - PubMed

LinkOut - more resources